Researchers have been excited about the medication , a novel dual compound showing promising outcomes in initial trials for weight reduction . It acts by impacting two pathways : GLP-1 and GIP, which https://bushraakxt826585.thelateblog.com/41117105/a-new-prospect-for-size-reduction